EUVIMEDEUVIMED entdecken
Crossref

Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway

Lintao Wang, Wu Luo, Suya Zhang, Junsheng Zhang, Lu He, Yifan Shi, Li Gao, Baochuan Wu, Xiaoyan Nie, Chenghong Hu, Xue Han, Chaoyong He und 2 weitere

Cardiovascular Research · 14.10.2024 · 120 (12) · 1385-1399

DOI: 10.1093/cvr/cvae131 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 06.06.2024. Verfasst von Lintao Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy and Institute of Inflammation, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, …. Hauptthemen laut MEDLINE: Receptor, Fibroblast Growth Factor, Type 1, Atherosclerosis, Phospholipase C gamma, NF-kappa B. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Atherosclerosis (AS) is a leading cause of cardiovascular morbidity and mortality. Atherosclerotic lesions show increased levels of proteins associated with the fibroblast growth factor receptor (FGFR) pathway. However, the functional significance and mechanisms governed by FGFR signalling in AS are not known. In the present study, we investigated fibroblast growth factor receptor 1 (FGFR1) signalling in AS development and progression. Methods and results Examination of human atherosclerotic lesions and aortas of Apoe−/− mice fed a high-fat diet (HFD) showed increased levels of FGFR1 in macrophages. We deleted myeloid-expressed Fgfr1 in Apoe−/− mice and showed that Fgfr1 deficiency reduces atherosclerotic lesions and lipid accumulations in both male and female mice upon HFD feeding. These protective effects of myeloid Fgfr1 deficiency were also observed when mice with intact FGFR1 were treated with FGFR inhibitor AZD4547. To understand the mechanistic basis of this protection, we harvested macrophages from mice and show that FGFR1 is required for macrophage inflammatory responses and uptake of oxidized LDL. RNA sequencing showed that FGFR1 activity is mediated through phospholipase-C-gamma (PLCγ) and the activation of nuclear factor-κB (NF-κB) but is independent of FGFR substrate 2.

Conclusion

Our study provides evidence of a new FGFR1–PLCγ–NF-κB axis in macrophages in inflammatory AS, supporting FGFR1 as a potentially therapeutic target for AS-related diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Fibroblast Growth Factor, Type 1AtherosclerosisPhospholipase C gammaNF-kappa BSignal TransductionMacrophagesDisease Models, AnimalAortic DiseasesPlaque, AtheroscleroticMice, Knockout, ApoEAnimalsMaleFemaleHumansMice, Inbred C57BLLipoproteins, LDLDiet, High-FatPyrazolesInflammation MediatorsBenzamidesProtein Kinase InhibitorsPiperazines

Stichwörter der Autor:innen

AtherosclerosisFGFR1InflammationMacrophageNuclear factor-κBOxidized LDL

Substanzen

Receptor, Fibroblast Growth Factor, Type 1Phospholipase C gammaNF-kappa BFgfr1 protein, mouseFGFR1 protein, humanPlcg1 protein, mouseoxidized low density lipoproteinAZD4547Lipoproteins, LDLPyrazoles

Autor:innen und Institutionen

  • Department of Pharmacy and Institute of Inflammation, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Shangtang Road 158, Hangzhou, Zhejiang 310014, China.
  • Department of Cardiology, Nanjing Drum Tower Hospital, State Key Laboratory of Pharmaceutical Biotechnology, Affiliated Hospital of Medical School, Nanjing University, Zhongshan Road 321, Nanjing, Jiangsu 210008, China.
  • State Key Laboratory of Natural Medicines, Department of Pharmacology, China Pharmaceutical University, Longmian Avenue 639, Nanjing, Jiangsu 210009, China.
  • Department of Cardiology, The Affiliated First Hospital of Wenzhou Medical University, Nanbaixiang Street, Wenzhou, Zhejiang 325035, China.
  • Department of Pathology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230032, China.
  • Department of Pathology, Anhui Public Health Clinical Center, Hefei, Anhui 230032, China.

ORCID-Profile: Biao Xu, Guang Liang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Wang, L., Luo, W., Zhang, S., Zhang, J., He, L., Shi, Y., Gao, L., Wu, B., Nie, X., Hu, C., Han, X., He, C., Xu, B., & Liang, G. (2024). Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway. Cardiovascular Research, 120(12), 1385-1399. https://doi.org/10.1093/cvr/cvae131

Vancouver

Wang L, Luo W, Zhang S, Zhang J, He L, Shi Y, et al. Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway. Cardiovascular Research. 2024;120(12):1385-1399. doi:10.1093/cvr/cvae131

BibTeX
@article{Wang2024,
  author = {Wang, Lintao and Luo, Wu and Zhang, Suya and Zhang, Junsheng and He, Lu and Shi, Yifan and Gao, Li and Wu, Baochuan and Nie, Xiaoyan and Hu, Chenghong and Han, Xue and He, Chaoyong and Xu, Biao and Liang, Guang},
  title = {Macrophage-derived FGFR1 drives atherosclerosis through PLCγ-mediated activation of NF-κB inflammatory signalling pathway},
  journal = {Cardiovascular Research},
  year = {2024},
  volume = {120},
  number = {12},
  pages = {1385--1399},
  doi = {10.1093/cvr/cvae131}
}
Kostenlos starten →